These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 34476973)

  • 1. A plea of those who are affected most by HIV: The utterances by women who inject Nyaope residing in the City of Tshwane Municipality, Gauteng.
    Lefoka MH; Netangaheni TR
    Afr J Prim Health Care Fam Med; 2021 Aug; 13(1):e1-e9. PubMed ID: 34476973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with smoking and transitioning to nyaope injection amongst women in the City of Tshwane Municipality: A self-report by women.
    Lefoka MH; Netangaheni RT
    Health SA; 2022; 27():1775. PubMed ID: 35937427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV risk behaviours among women who inject drugs in coastal Kenya: findings from secondary analysis of qualitative data.
    Mburu G; Limmer M; Holland P
    Harm Reduct J; 2019 Feb; 16(1):10. PubMed ID: 30728012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developing integrated community-based HIV prevention, harm reduction, and sexual and reproductive health services for women who inject drugs.
    Ayon S; Jeneby F; Hamid F; Badhrus A; Abdulrahman T; Mburu G
    Reprod Health; 2019 May; 16(Suppl 1):59. PubMed ID: 31138238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A qualitative analysis of transitions to heroin injection in Kenya: implications for HIV prevention and harm reduction.
    Guise A; Dimova M; Ndimbii J; Clark P; Rhodes T
    Harm Reduct J; 2015 Sep; 12():27. PubMed ID: 26337729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "We don't need services. We have no problems": exploring the experiences of young people who inject drugs in accessing harm reduction services.
    Krug A; Hildebrand M; Sun N
    J Int AIDS Soc; 2015; 18(2 Suppl 1):19442. PubMed ID: 25724510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective cohort study of risk behaviours, retention and loss to follow-up over 5 years among women and men in a needle exchange program in Stockholm, Sweden.
    Karlsson N; Kåberg M; Berglund T; Hammarberg A; Widman L; Ekström AM
    Int J Drug Policy; 2021 Apr; 90():103059. PubMed ID: 33360734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population estimation and harm reduction among people who inject drugs in Addis Ababa, Ethiopia.
    Deyessa N; Senbete B; Abdo A; Mundia BM
    Harm Reduct J; 2020 Sep; 17(1):61. PubMed ID: 32894153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tales of gender-based oppression and violence: Risks and vulnerabilities of women who inject drugs (WWID) in Dhaka, Bangladesh.
    Irfan SD; Khan MNM; Khan SI
    Int J Drug Policy; 2021 Jun; 92():103144. PubMed ID: 33549468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A qualitative study of facilitators and barriers to participate in a needle exchange program for women who inject drugs.
    Värmå Falk M; Strömdahl S; Ekström AM; Kåberg M; Karlsson N; Dahlborn H; Hammarberg A
    Harm Reduct J; 2020 Oct; 17(1):84. PubMed ID: 33092595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barriers and facilitators of access to HIV, harm reduction and sexual and reproductive health services by women who inject drugs: role of community-based outreach and drop-in centers.
    Ayon S; Ndimbii J; Jeneby F; Abdulrahman T; Mlewa O; Wang B; Ragi A; Mburu G
    AIDS Care; 2018 Apr; 30(4):480-487. PubMed ID: 29067855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical Providers and Harm Reduction Views on Pre-Exposure Prophylaxis for HIV Prevention Among People Who Inject Drugs.
    Hershow RB; Gonzalez M; Costenbader E; Zule W; Golin C; Brinkley-Rubinstein L
    AIDS Educ Prev; 2019 Aug; 31(4):363-379. PubMed ID: 31361517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Harm reduction in practice - The Community Oriented Substance Use Programme in Tshwane.
    Scheibe A; Shelly S; Hugo J; Mohale M; Lalla S; Renkin W; Gloeck N; Khambule S; Kroukamp L; Bhoora U; Marcus TS
    Afr J Prim Health Care Fam Med; 2020 May; 12(1):e1-e6. PubMed ID: 32501031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retention of service users on opioid substitution therapy in the City of Tshwane, South Africa.
    Goeieman DS; Nonyane DS; Nzaumvila DK; Anse van Rensburg MNS
    Afr J Prim Health Care Fam Med; 2023 Jan; 15(1):e1-e10. PubMed ID: 36744456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV, HCV, and Health-Related Harms Among Women Who Inject Drugs: Implications for Prevention and Treatment.
    Iversen J; Page K; Madden A; Maher L
    J Acquir Immune Defic Syndr; 2015 Jun; 69 Suppl 2(0 1):S176-81. PubMed ID: 25978485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experiences and coping strategies of parents living with adolescents misusing
    Masombuka J; Mathibela F
    Health SA; 2022; 27():2042. PubMed ID: 36483512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV- and hepatitis C-related risk behaviors among people who inject drugs in Uganda: implications for policy and programming.
    Baluku M; Wamala T; Muhangi D
    Harm Reduct J; 2019 Sep; 16(1):56. PubMed ID: 31481086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Social context, diversity and risk among women who inject drugs in Vietnam: descriptive findings from a cross-sectional survey.
    Khuat OT; Morrow M; Nguyen TN; Armstrong G
    Harm Reduct J; 2015 Oct; 12():35. PubMed ID: 26472467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV prevalence and risk among people who inject drugs in five South African cities.
    Scheibe A; Makapela D; Brown B; dos Santos M; Hariga F; Virk H; Bekker LG; Lyan O; Fee N; Molnar M; Bocai A; Eligh J; Lehtovuori R
    Int J Drug Policy; 2016 Apr; 30():107-15. PubMed ID: 26860326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innovative community-based educational face-to-face intervention to reduce HIV, hepatitis C virus and other blood-borne infectious risks in difficult-to-reach people who inject drugs: results from the ANRS-AERLI intervention study.
    Roux P; Le Gall JM; Debrus M; Protopopescu C; Ndiaye K; Demoulin B; Lions C; Haas A; Mora M; Spire B; Suzan-Monti M; Carrieri MP
    Addiction; 2016 Jan; 111(1):94-106. PubMed ID: 26234629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.